AstraZeneca Adds High-Tech Biologics Bulk Manufacturing Facility In Boulder, Colorado
09/11/2015
Pam Cheng, Executive Vice-President, Operations and Information Technology at AstraZeneca, said, “The addition of the Boulder facility will support the progression of biotech drug candidates across our main therapeutic areas as we continue to bring innovative new treatments to patients. This site will play an important role in our future commercial production and give AstraZeneca and MedImmune, our global biologics research and development arm, the flexibility and capacity to meet the needs of our rapidly growing biologics portfolio.”
Over time, the LakeCentre facility, in Boulder, will increase manufacturing and production capacity to support the company’s extensive portfolio of biologics medicines. AstraZeneca plans to start staffing the facility immediately to support refurbishment and infrastructure improvements. Once complete, the site is expected to be operational and licensed for commercial production by late 2017, providing for additional capacity within the company’s biologics operations.
In the longer- term, this site could create up to 400 highly skilled jobs, subject to relevant approvals by the local authorities, company officials said. The facility will eventually double the biologics manufacturing capacity in the US to meet the needs of the maturing AstraZeneca pipeline. Currently biologics make up 50 percent of the company’s pipeline with more than 120 ongoing programmes, including over 30 in clinical development.
Project Announcements
Oldcastle APG Plans Lancaster, South Carolina, Operations
05/10/2025
Vantive Plans Deerfield, Illinois, Headquarters Operations
05/10/2025
SkyWest Airlines Plans Shreveport, Louisiana, Maintenance Operations
05/10/2025
Hissho Sushi Plans Rock Hill, South Carolina, Headquarters-Distribution Operations
05/09/2025
Nelson Brothers Expands Walker County, Alabama, Operations
05/04/2025
Kimberly-Clark Expands Aiken County, South Carolina, Distribution Operations
05/04/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
The Location Economics of Advanced Nuclear
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Is It Time to Start Planning for Quantum Data Centers?
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024